Home Legal Mounjaro Lawsuit

Mounjaro Lawsuit

Mounjaro, a diabetes drug made by Eli Lilly, is at the center of lawsuits that claim it caused severe stomach issues like vomiting, gastroparesis and intestinal blockages. Plaintiffs allege the company should have known about the dangers and failed to warn doctors and patients of the risks.

See If You Qualify for a Weight Loss and Diabetes Drug Lawsuit

You may be entitled to compensation if you were injured after taking a medication like Ozempic, Saxenda or Wegovy. For a free case review, complete the form or call 866-898-3173.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

  • A+BBB Rating
  • 4.9 StarGoogle Reviews
Fact Checked
Expert Verified

Our content is developed and backed by respected legal, medical and scientific experts. More than 30 contributors, including product liability attorneys and board-certified physicians, have reviewed our website to ensure it’s medically sound and legally accurate.

Why Trust Drugwatch?
Drugwatch is trusted
legal help when you need it most.

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by Wilson & Peterson LLP, we've pursued justice for more than 20,000 families and secured $324 million in settlements and verdicts against negligent manufacturers.

More than 30 contributors, including mass tort attorneys and board-certified doctors, have reviewed our website and added their unique perspectives to ensure you get the most updated and highest quality information.

Drugwatch.com is AACI-certified as a trusted medical content website and is produced by lawyers, a patient advocate and award-winning journalists whose affiliations include the American Bar Association and the American Medical Writers Association.

About Drugwatch.com

  • 15+ Years of Advocacy
  • $324 Million Recovered for Clients
  • 20,000 Families Helped
  • A+ BBB Rating
  • 4.9 Stars from Google Reviews
Learn More About Us

Testimonials

I found Drugwatch to be very helpful with finding the right lawyers. We had the opportunity to share our story as well, so that more people can be aware of NEC. We are forever grateful for them.
Chasity P. Legal Client
  • Google Business Rating
  • BBB A+ Rating Logo
Did you experience serious side effects after taking a diabetes & weight loss drug such as Ozempic or Wegovy?

Why Are People Suing Eli Lilly Over Mounjaro?

People are suing Eli Lilly, the maker of Mounjaro, claiming the drug caused serious complications like stomach paralysis (gastroparesis) and intestinal blockages.

Mounjaro treats Type 2 diabetes. It’s also being used for weight loss despite not having U.S. Food & Drug Administration (FDA) approval.

However, some users say they weren’t warned about the drug’s risks.

As lawsuits emerged, multidistrict litigation (MDL) was established in Pennsylvania to handle the cases. MDLs consolidate similar lawsuits in a single federal court, streamlining legal proceedings and ensuring consistent court rulings.

A federal panel combined the Mounjaro lawsuits with other claims related to similar medications. These include Wegovy, Trulicity and Ozempic.

Case Study: Jaclyn Bjorklund Mounjaro Lawsuit

Jaclyn Bjorklund, a woman from Louisiana, sued the makers of Ozempic (Novo Nordisk) and Mounjaro (Eli Lilly). Her lawyers say the companies failed to adequately warn patients about serious stomach problems linked to the drugs.

After using Ozempic and Mounjaro for Type 2 diabetes, Bjorklund says she suffered from severe vomiting, stomach pain and gastroparesis. She was hospitalized multiple times, lost teeth from vomiting and had to take more medications to help with her symptoms.

Bjorklund claims the drugmakers knew about these risks but did not give clear warnings. She is suing for permanent injuries, pain, emotional distress and the cost of her medical care.

Common Legal Allegations in Mounjaro Lawsuits

Mounjaro lawsuits allege that Eli Lilly failed to adequately warn patients and doctors about the serious stomach problems associated with the drug. Plaintiffs claim that Eli Lilly knew or should have known about these risks but didn’t communicate them clearly.

The lawsuits also accuse the company of making misleading statements about the safety of the drug.

Some users who took Mounjaro with other medications, like those from Novo Nordisk, claim one or both caused them harm. The lawsuits seek compensation for medical costs, pain and suffering.

Medical and Legal Perspectives on Mounjaro Lawsuits

Drugwatch Analysis (September 2025)

Mounjaro lawsuits highlight rising concerns about the safety of this diabetes medication from Eli Lilly. Patients claim that the company did not sufficiently warn them or their doctors about serious stomach issues, such as nausea and intestinal blockages.

These cases have been combined into a larger legal proceeding in Pennsylvania to streamline similar injury claims. Much of the focus is on whether Eli Lilly was aware of these dangerous side effects but chose not to disclose them. 

As the legal process unfolds, patients affected by the incident are seeking compensation for their injuries and medical expenses.

Mounjaro Lawsuit Latest Updates

Mounjaro lawsuits are part of MDL 3094 in the U.S. District Court for the Eastern District of Pennsylvania. As of September 2025, there were 2,676 lawsuits pending in the MDL.

Not all of the cases are Manjaro-specific. Several different Type 2 diabetes drugs in the same class, known as glucagon-like peptide-1 receptor agonists, are included in the MDL.

GLP-1 Drugs Included in the GLP-1 MDL
Latest Updates in Mounjaro Lawsuits
  • June 2025:
    As of June 2, 2025, there are 1,882 active cases in the MDL.
  • March 2025:

    Defendants in the MDL filed a motion to dismiss some of the stomach paralysis claims made in the plaintiffs’ master complaint. This motion does not impact the failure-to-warn claims that are at the heart of the litigation.

    Plaintiffs in the MDL later filed a response to the motion to dismiss some claims. They argue that the law only requires plausible claims backed by facts during discovery.

  • September 2024:
    There was a big jump in the number of lawsuits filed in the MDL. The number of active cases rose from 346 at the start of August to 869 in the first week of September.
  • June 2024:
    Judge Karen S. Marston took over the MDL following the death of Judge Pratter.
  • May 2024:
    The presiding judge in the Mounjaro MDL, U.S. District Judge Gene E. K. Pratter, died on May 17. The Judicial Panel on Multidistrict Litigation had to reassign the case to a new judge, prompting delays in the litigation.
  • May 2024:
    Judge Pratter named Paul Pennock of Morgan & Morgan and other attorneys to the MDL's Plaintiffs’ Committee. These committees help guide the litigation while representing all plaintiffs in the MDL.
  • February 2024:
    A total of 55 lawsuits against GLP-1 RAS class drugs were consolidated into an MDL in Pennsylvania.
  • December 2023:
    Novo Nordisk attempted to get Jaclyn Bjorklund's Ozempic lawsuit dismissed, but a judge cleared it to proceed.
  • September 2023:
    Eli Lilly filed lawsuits against compounding pharmacies, medspas and wellness centers over the fraudulent distribution of counterfeit products labeled as Mounjaro.
  • August 2023:
    Law firm Morgan & Morgan filed a claim in federal district court on behalf of its client, Jaclyn Bjorklund. The named defendants are Novo Nordisk and Eli Lilly. Bjorklund alleges the companies failed to warn patients about the risks of stomach paralysis associated with Ozempic and Mounjaro.
  • May 2022:
    The FDA approved Eli Lilly’s Mounjaro to help control blood sugar levels in patients with Type 2 diabetes. The approval notes the risk of gastrointestinal side effects.

Who Qualifies To File a Mounjaro Lawsuit?

If you took Mounjaro for Type 2 diabetes or weight loss and developed certain severe side effects or injuries, you may qualify to file a Mounjaro lawsuit.

Injuries That Make You Eligible To File a Mounjaro Lawsuit
  • Blurry or lost vision
  • Deep vein thrombosis
  • Gastrointestinal injuries like gastroparesis, persistent vomiting or bowel obstruction
  • Pancreatic cancer
  • Pulmonary aspiration

If you’ve been harmed by Mounjaro, start by getting medical care and saving all your records. Report your side effects to the FDA’s MedWatch program. Then, talk to a lawyer to learn about your legal rights.

Drugwatch can help you take action if you want to hold drugmakers accountable and ensure the safety of others.

See if You Qualify for a Lawsuit Our Partners

Our Trusted Legal Partners

Drugwatch partners with trusted law firms to help you take legal action. After submitting the form, one of Drugwatch's partners will contact you for a free case review.

simmons hanly conroy law firm logo weitz and luxenberg logo sokolove law firm logo levin papantonio rafferty law firm logo nigh goldenberg raso and vaughn law firm logo morgan & morgan logo the ferraro law firm logo meirowitz & wasserberg law firm logo

How To File a Mounjaro Lawsuit

If you are considering filing a Mounjaro lawsuit, you can request a free case review through Drugwatch. You’ll fill out a short form, and then we will contact you to ask a few questions about your experience with Mounjaro. These questions will help determine if you have a case.

Case reviews are completely free. There’s no pressure to file a lawsuit. Whether you decide to move forward or not, you’ll get trusted information and support.

Drugwatch partners with leading national law firms that specialize in mass torts, personal injury and dangerous drug cases. Our goal is to connect you to the best attorney for your injuries.

It’s helpful to gather your medical records and act quickly. Legal deadlines to file a case vary by state.

Filing a Mounjaro lawsuit isn’t just about money. It’s about holding drugmakers accountable and protecting others from harm.

Please seek the advice of a medical professional before making health care decisions.